Amc Pharma
bio pharma company with a subsidiary that constructs modular hospitals
Based in FL
AI Overview
With $150K in lobbying spend across 8 quarterly filings, Amc Pharma is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2023 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $90K |
| 2024 | $60K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Amc Pharma disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations
funding for the construction of modular hospitals in Tampa, FL (and other domestic manufacturing facilities) for sale to a wide range of purchasers both domestically and globally
HR 5860, Continuing Appropriations Act, 2024 and Other Extensions Act for appropriations on a hospital project
Title XIII of the International Financial Institutions Act of 1977, as Amended (IFIA) for US based healthcare system to foreign countries
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.